Search results
Order by most recent / most popular / relevance
Results: 1-4 of 4
Data protection in Canada: too much? Too little?
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- June 28 2011
Prior to the enactment in 2006 of the amendments to section C.08.004.1 of the Food and Drugs Regulations (Data Protection Regulations), Canada did not have an effective regime of data protection exclusivity
First PMPRB decision dismissing allegations of excessive pricing
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- April 20 2010
The Patented Medicine Prices Review Board ("PMPRB") recently released its decision in the matter of Hoechst Marion Roussel Canada Inc. and the medicine NIOCODERM, a nicotine patch which assists those who are attempting to quit smoking; it is to be publicly posted on the PMPRB website today
PMPRB issues first vaccines pricing decision
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- February 4 2010
In a decision dated December 21, 2009 (and published on the PMRPB website on January 28, 2010) the Patented Medicine Prices Review Board ("PMPRB") decided the merits of the matter of Sanofi Pasteur Limited and the medicines Quadracel and Pentacel, which are multi-component vaccines designed to protect against multiple diseases
Court overturns PMPRB's decisions in respect of the medicine copaxone
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- November 18 2009
On November 12, 2009, Justice Hughes of the Federal Court allowed two judicial review applications of Teva Neuroscience G.P.-S.E.N.C. in respect of two decisions made by the Patented Medicine Prices Review Board
Current Search
- Workarea - Intellectual Property
- Workarea - Healthcare
- Author - Graham Ragan